Police have apprehended a man after he attempted twice to assault a minor in Thakhak District, Khammouane Province.
Laos Reports a Trade Deficit of USD 45 Million in November
According to the Lao Trade Portal, the November trade deficit figure of USD 45 million is quite low compared to September and October figures of USD 233 million and USD 230 million respectively.
Heineken, Loca Team Up to Curb Drunk Driving in Vientiane
Heineken® has teamed up with LOCA to create awareness of “when you drink, never drive” and provide incentives to curb drunk driving behavior in Vientiane, Laos. The partnership offers incentives for drinkers to ride to their favorite bar and return back home safely using LOCA.
Steward Leadership 25 Unveiled at Steward Leadership Summit
25 initiatives from organisations within the Asia-Pacific region selected for steward leadership excellence
SINGAPORE – Media OutReach – 21 December 2022 – Stewardship Asia Centre (SAC), INSEAD Hoffmann Global Institute for Business and Society, WTW and The Straits Times unveiled the Steward Leadership 25 (SL25), the inaugural annual listing of 25 organisational initiatives that showcased notable efforts to create a collective better future for stakeholders, society, future generations and the environment.
The 25 initiatives were honoured at the Steward Leadership Summit, which was held at Shangri-La Singapore on 30 November. The inaugural event was organised by SAC to highlight the importance of steward leadership across the Asia Pacific. Mr Chan Chun Sing, Minister for Education, Singapore, graced the event as the guest of honour and delivered the keynote address. Some 350 participants attended the event.
Steward leadership excellence demands genuine desire and persistence to pursue a corporate agenda beyond profit-making.
The 25 were selected from 95 submissions across the Asia-Pacific region. They were from diverse industries, including financial services, transportation, agribusiness and real estate. These initiatives were chosen for their steward leadership strategy and actions in creating sustainable economic value, and all 25 hold equal merit.
“A rapidly changing world reinforces the principle of taking ownership to do the right thing, and a mindset shift that is critical to driving all of us to work together towards enduring value creation for the benefit of stakeholders, society, the environment and our future generations. These organisations’ initiatives have made a difference, and I hope they will inspire others to act,” said Mr Lim Boon Heng, Chairman of Temasek Holdings, who unveiled the inaugural list at the Steward Leadership Summit.
“It is really heartening to see the efforts and persistence of so many organisations striving to create lasting positive change in the environment and community. In honouring these 25 inspirational initiatives, our eventual goal is for steward leadership excellence to be the norm instead of the exception, where every firm is committed to establishing a win-win-win outcome for employees, shareholders and society at large,” said Mr Rajeev Peshawaria, CEO of SAC.
“I hope the SL25 list will encourage other companies to look beyond their shareholders, to include their employees, customers, suppliers, and the larger communities that they operate within and be effective stewards for all. By intentionally delivering profit with purpose, responsible business leaders can prioritise the needs of current and future generations and our planet. As the recent discussions at COP 27 have highlighted, the problems that we need to solve require the combined and urgent stewardship efforts of all of us,” said Dr Vinika D. Rao, Executive Director of INSEAD Emerging Markets Institute, Gender Initiative and Africa Initiative, and Asia Director of the Hoffmann Global Institute for Business & Society.
“Progressive companies have moved past the moral imperative and are realising the tangible business benefits. WTW is proud to be associated with this list of SL25 so that we can help shine the spotlight on progressive companies, across various sectors and sizes and company types, that are role models for balancing purpose, profits, people and planet,” said Mr Shai Ganu, Managing Director and Global Leader of the Executive Compensation & Board Advisory at WTW.
“At The Straits Times, we have been covering developments in Singapore, Asia and the world since 1845, helping our readers understand events around them. Especially at this time of significant economic, environmental and geopolitical uncertainty, it is heartening to learn of and support the efforts of companies which aim to do good for all their stakeholders,” said Mr Jaime Ho, Editor of The Straits Times, SPH Media Trust.
Mr Frank E. Mars, Board Chair and Advisor, Strategic Programs, Mars, Incorporated, joined the summit virtually. He highlighted the role of corporate organisations in solving today’s existential challenges, based on his discussion theme with Mr Peshawaria, “Successful Stewardship Requires More Than a Purpose.”
Mr Jaime Alfonso Zobel de Ayala, Head of Business Development and Digital Innovation, Ayala Corporation, explained how the Philippine conglomerate balanced profit and purpose.
Ms Erika Cheung, Co-Founder and Executive Director, Ethics in Entrepreneurship, and a former Theranos employee, talked about her courage to speak out and highlighted the importance of corporate ethics.
Ms Aw Kah Peng, Chairman of Shell Companies in Singapore, Mr Bey Soo Khiang, Vice-Chairman at RGE and Chairman of APRIL Group, and Mr Edward Booty, reach52’s CEO, tackled the issue of whether “Can Addressing Existential Challenges Be Profitable?” The panel discussion was moderated by Mr Munib Madni, Founding Panvestor and CEO, Panarchy Partners.
In the second panel, Professor Tommy Koh, Ambassador-at-Large, Ministry of Foreign Affairs, Singapore, Dr Vinika D. Rao, Mr Jamie Ho and Tan Sri Dr Rebecca Fatima Sta Maria, Executive Director, Asia-Pacific Economic Cooperation Secretariat, Singapore, shared the key highlights from the SL25 initiatives. Mr Shai Ganu was the moderator.
The SL25 initiatives and their companies (in alphabetical order) are:
Initiative Title | Organisation | Industry | Geography | Category | |
1 | Improving the livelihoods of motorcycle taxis | Angkas | Transportation | Philippines | SME |
2 | Transforming workplaces for gender inclusion | Avtar Group | Human Resource Consulting | India | SME |
3 | Steering a collective Covid-19 response | Ayala Corporation | Conglomerate | Philippines | MNC |
4 | Climate action through voting and engagement | BNP Paribas Asset Management | Financial Services | Singapore | MNC |
5 | Innovating sustainability for the built environment | CapitaLand Investment Limited | Real Estate | Singapore | MNC |
6 | Constructing collaborative spaces to empower sustainability | City Developments Limited | Real Estate | Singapore | MNC |
7 | A different kind of bank | DBS Bank Limited | Financial Services | APAC | MNC |
8 | Fuelling growth with renewables, community art | Faber-Castell AG | Writing and Colouring Instrument | APAC | MNC |
9 | Producing dairy through sustainable farming | Farm Fresh Berhad | Food and Beverage | Malaysia | MNC |
10 | A work-integration model for social inclusion | Foreword Coffee Pte. Ltd. | Food Services | Singapore | Social Enterprise |
11 | Providing work opportunities for disadvantaged groups | Genashtim Pte. Ltd. | Corporate Services | Singapore | Social Enterprise |
12 | Scaling sustainable impact through ecosystem management | GUAVA Amenities | Hospitality and Travel | APAC | SME |
13 | Protecting Java’s coffee and primate landscape | Mandai Wildlife Group | Conservation and Education | Indonesia | SME |
14 | Equipping farmers with sustainable agricultural methods | Marico Limited | Consumer | India | MNC |
15 | Ahead in net positive carbon and gender equality | Mirvac Group | Real Estate | Australia | MNC |
16 | Enabling financial well-being for low-income households | Noburo Platform Co., Ltd. | Financial Services | Thailand | Social Enterprise |
17 | Driving the green movement | Oversea-Chinese Banking Corporation Limited | Financial Services | Singapore | MNC |
18 | Addressing health access in rural areas | reach52 | Healthcare | APAC | Social Enterprise |
19 | From tin-mining wasteland to sustainable township | Sunway Group | Conglomerate | Malaysia | MNC |
20 | Enabling communities through technology | Tata Consultancy Services | Technology | Singapore | MNC |
21 | Creation of bioplastic from farm-led innovation | Thai Wah Public Company Limited | Agribusiness | Thailand | MNC |
22 | Creating plant-based food, PWD opportunities | The Social Kitchen Pte. Ltd. | Hospitality | Singapore | Social Enterprise |
23 | Bio-innovation for food security and sustainability | UAL Biotech Pte. Ltd. | Agribusiness | APAC | SME |
24 | Directing capital towards UN SDGs | UBS AG | Financial Services | APAC | MNC |
25 | Collaborating to drive a sustainable ASEAN | United Overseas Bank Limited | Financial Services | APAC | MNC |
Hashtag: #StewardLeadership25
The issuer is solely responsible for the content of this announcement.
About Steward Leadership 25
Jointly curated by Stewardship Asia Centre, the INSEAD Hoffmann Global Institute for Business and Society, WTW and The Straits Times, Steward Leadership 25 (SL25) is an annual listing of 25 initiatives that showcase steward leadership excellence within the Asia-Pacific region. SL25 highlights narratives from organisations that have demonstrated resolute actions in pursuing and achieving their unique versions of stewardship purpose while living stewardship values such as interdependence and long-term view. Organisational initiatives included in the SL25 list would have demonstrated steward leadership in strategy, execution and shaping culture.
Inclusion to the SL25 list is based on the particular initiative(s) described in the nomination form. SL25 is not intended as a blanket endorsement of the organisation as a whole. The organisations are responsible for the truthfulness, accuracy and completeness of their nominations, which are not guaranteed by the SL25 partners.
Doctor Anywhere acquires Singapore-listed Asian Healthcare Specialists, secures additional US$38.8 million funding
Acquisition of integrated healthcare provider Asian Healthcare Specialists marks expansion of strategic capabilities, builds holistic healthcare offering to serve Southeast Asia
SINGAPORE – Media OutReach – 21 December 2022 – Doctor Anywhere (DA), a regional tech-led healthcare company headquartered in Singapore, announced that it has acquired Catalist-listed Asian Healthcare Specialists (SGX:1J3), an integrated healthcare provider in Singapore.

Asian Healthcare Specialists is a group of 14 medical specialists, with a patient-first approach and vision to make specialised care accessible to all. Its 12 specialist clinics across multidisciplinary specialities comprise orthopaedics, ophthalmology, dermatology, urology, gastroenterology, otorhinolaryngology, anaesthesia, family medicine and rehabilitation – all areas that complement DA’s regional healthcare services and offer consumers greater access to complex treatments.
The acquisition is a strategic step to further DA’s long-term growth ambitions, enabling it to deliver more holistic healthcare and meet the rising demand for complex, specialised treatment across Southeast Asia.
“Our goal at Doctor Anywhere is to build a digital healthcare ecosystem to enable better patient outcomes and help shape the future of healthcare in Southeast Asia. With consumers across the region seeking higher quality and more personalised care, the acquisition of Asian Healthcare Specialists strengthens our capabilities beyond our successful primary care services, enabling us to deliver more integrated, holistic care and greater value for our users,” said Lim Wai Mun, Founder & CEO, Doctor Anywhere.
“We continue to be on the lookout for synergistic opportunities and targeted acquisitions of critical healthcare assets across the region, which will enable us to further the work we have begun on building a regional healthcare ecosystem that leverages technology and innovation. A more diversified and holistic range of integrated healthcare service offerings will enable Doctor Anywhere to deliver greater value and impact to elevate the region’s healthcare outcomes,” added Wai Mun.
Chief Executive Officer of Asian Healthcare Specialists Limited, Dr Chin Pak Lin commented, “Coupled with shifting demographics, technological innovations, and the diverse nature of healthcare infrastructure across Southeast Asia, we’re currently sitting at the nexus of potential transformation. We are excited to join Southeast Asia’s largest omni-channel healthcare provider and bring our well-established specialist care expertise to the group. We look forward to working together to bridge the gap between primary and specialised care to provide seamless, holistic care that transcends boundaries and statuses.”
Additional funding bolstered by latest Series C1 financing round
Doctor Anywhere also announced a US$38.8 million Series C1 financing round, an up round led by Novo Holdings, a leading international life science investor. Other existing shareholders also participated in the round, including Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, EDBI and OSK-SBI Venture Partners.
The funding will be used to accelerate growth and to partly fund the acquisition of Asian Healthcare Specialists. It comes just over a year after the company raised a US$65.7 million Series C in August 2021 in one of the largest private funding rounds ever raised by a healthtech company in Southeast Asia. This brings the total capital raised by Doctor Anywhere to nearly US$140 million.
“Doctor Anywhere has shown an exceptional track record since its inception, and today it has firmly established itself as a regional leader in healthcare, successfully integrating seamless online and offline approaches to bring easily accessible and affordable healthcare to millions across Southeast Asia,” said Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia.
“We are confident in DA’s growth as it builds a regional ecosystem to bring delivery of patient care to the next level, in line with its vision to become the leading tech-enabled omnichannel healthcare provider in Southeast Asia,” he added.
Carol Wang, Senior Associate at Novo Holdings Equity Asia, added: “We are particularly excited to lead this up round to fund the accretive acquisition of Asian Healthcare Specialists. With the addition of the synergistic specialist clinics, we believe that DA would further enhance patient journeys seamlessly through its fully integrated online and offline offerings and would further differentiate itself as a leading omnichannel healthcare provider in Southeast Asia, enabled by its innovative technologies. We look forward to continuing to back DA’s long-term vision, which is perfectly aligned with our deep expertise and commitment in tech-enabled healthcare services.”
Hashtag: #DoctorAnywhere
The issuer is solely responsible for the content of this announcement.
About Novo Holdings
Novo Holdings is a holding and investment company that is responsible for managing the operating and financial assets of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.
Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk and Novozymes (the Novo Group companies) and manages an investment portfolio, with a long-term return perspective. The investment portfolio comprises two teams: Life Science Investments and Novo Capital Investors. The Life Science Investments team invests in companies at all stages of development and includes Novo Seeds, Novo Ventures, Novo Growth and Principal Investments. The Novo Capital Investors team manages a broad portfolio of equities, bonds, real estate and infrastructure assets, as well as private equity investments.
Novo Holdings operates out of offices in Copenhagen, London, Boston, San Francisco, Singapore and Shanghai. As of year-end 2021, Novo Holdings had total assets of USD 106 billion. Further information: www.novoholdings.dk.
About Doctor Anywhere
Doctor Anywhere is a regional tech-enabled, omnichannel healthcare company, on a mission to make healthcare simple, accessible, and efficient for everyone. Doctor Anywhere’s digital platform bridges gaps in the healthcare ecosystem through technology and innovation, enabling users to manage their health easily and effectively through the DA mobile app. Headquartered in Singapore and with a presence in six countries across the region, Doctor Anywhere now serves more than 2.5 million (and growing) users across Southeast Asia. For more information, visit: http://www.doctoranywhere.com
About Asian Healthcare Specialists
Asian Healthcare Specialists Limited is incorporated in Singapore and listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”), and the Company’s sponsor is RHT Capital Pte. Ltd. The Group is a multidisciplinary medical services group providing an extended range of medical services such as anaesthesia, dermatology, family medicine, gastroenterology, ophthalmology, orthopaedics, otorhinolaryngology, rehabilitation and urology. The Group currently has 14 medical specialists in different divisions, one family physician and one physiotherapist, located at 12 clinics in Singapore.
Hong Kong Life Launches “Family Guardian Refundable Hospital Income Protection Plan” with Market-first Family Daily Hospital Income Benefit Providing 100% Premium Refund and additional No Claim Bonus upon Maturity
Mr. Jonathan Ko, the Chief Marketing Officer of Hong Kong Life, said, “We understand that most customers are willing to strengthen their life and healthcare protection for both individual and family after the pandemic. Compared with most of the hospital income insurance plans in the market which mainly provide personal protection, Family Guardian Refundable Hospital Income Protection Plan is specially designed with family protection feature. The first-in-market# Family Daily Hospital Income Benefit showcases the customer-centric philosophy of Hong Kong Life. Customer and his designated family member are covered with daily hospital income protection by one premium budget, providing peace-of-mind for unexpected hospitalization expenses in case of emergencies.”
Limited Time Offer of First Year Premium Discount
From now until 30 June 2023, customers may enjoy 10% first year premium discount upon successful application of Family Guardian Refundable Hospital Income Protection Plan.
Product Features of “Family Guardian Refundable Hospital Income Protection Plan”:
- Daily Hospital Income for Flexible Use
If the Life Insured is confined in hospital due to Injury or Sickness while the Plan is in force and prior to the Maturity Date, the Daily Hospital Income Benefit1 will be paid for each day of Hospital Confinement2, with a maximum number of days of Hospital Confinement2 up to 1,000 days per Disability.
- Intensive Care Benefit
If the Life Insured is confined in Intensive Care Unit due to Injury or Sickness while the Plan is in force and prior to the Maturity Date, in addition to the Daily Hospital Income Benefit, the Intensive Care Benefit1 will be paid for each day of Hospital Confinement2 only when the Daily Hospital Income Benefit is also payable for the same Disability, with a maximum number of days of Hospital Confinement2 up to 90 days per Disability.
- 3 Classes of Daily Hospital Income
The Plan provides 3 classes of Daily Hospital Income for selection, i.e., HKD600, HKD1,000 and HKD1,500 in order to meet your need.
- 10-Year Protection with Premium Refund
The Plan offers 10 years of protection to the Life Insured. Also, the Plan provides premium refund. Maturity Benefit which is equal to 100% of Total Premiums Paid will be paid if the Life Insured is then alive on the Maturity Date. Provided that no death claim is made in the benefit term of the Plan, if you surrender the Policy prior to the Maturity Date, the Surrender Benefit will be paid to the Policyowner. The Surrender Benefit equals to a percentage of Total Premiums Paid for the Plan by referring to the Schedule of Surrender Benefit in “Benefit Coverage” at the time of surrender.
- No Claim Bonus
If the Life Insured is then alive on the Maturity Date, provided that no surrender and no claim has been made under Daily Hospital Income Benefit1 (or Family Daily Hospital Income Benefit1,3, where applicable), Intensive Care Benefit1 or Surrender Benefit, an extra 3% of Total Premiums Paid will be paid as No Claim Bonus.
- Life Protection for Peace of Mind
Apart from Daily Hospital Income Benefit, the Plan also offers life protection. If the Life Insured dies while the Plan is in force and prior to the Maturity Date, the Guaranteed Death Benefit which is equal to 105% of Total Premiums Paid will be paid to the Beneficiary.
- Additional Protection and Service to Meet the Needs of You and Your Family
First-in-Market# Family Daily Hospital Income Benefit1,3
The Plan specially offers Family Daily Hospital Income Benefit1,3 to one of the Policyowner’s spouse or children (except the Life Insured). No medical examination and health questions are required for the Covered Family Member. If the Covered Family Member is confined in hospital due to Injury or Sickness while the Plan is in force and prior to the Maturity Date, the Family Daily Hospital Income Benefit1,3 will be paid to the Policyowner for each day of Hospital Confinement2. Throughout the benefit term of the Plan, the maximum number of days of Hospital Confinement2 for Family Daily Hospital Income Benefit1,3 is 10 days.
Second Medical Opinion from Overseas Expert Service4
If the Life Insured has been diagnosed with the dread disease covered by the service, the service enables the Life Insured to seek second medical opinion from overseas experts4.
- Fixed Premium for Your Better Planning
The premium will remain unchanged throughout the Premium Payment Term5, allowing you to have a better plan for your future.
- Simple Application
Application procedure is simple and no medical examination is required.
For more details of the Family Guardian Refundable Hospital Income Protection Plan, please visit https://www.hklife.com.hk/en/products/personal-insurance/medical-dread-disease-plan/family-guardian-refundable-hospital-income-protection-plan/index.html
Terms and Conditions apply. For enquiries, please contact our Customer Service Hotline at 2290 2882 or visit Hong Kong Life website www.hklife.com.hk.
Remarks:
# “First-in-market” is stated by comparing to the same type of hospital income insurance products on the market as of September 2022 when Family Guardian Refundable Hospital Income Protection Plan was first launched.
- The Daily Hospital Income Benefit (or Family Daily Hospital Income Benefit, where applicable) or Intensive Care Benefit is only payable once for any one day of Hospital Confinement, regardless of the number of Disability per Hospital Confinement. If more than one Hospital Confinement are caused by the same or related Disability, Hong Kong Life will regard such multiple Hospital Confinements as being caused by the same Disability. In the case where Hospital Confinement occurs in places other than Hong Kong, Macau, Singapore, Malaysia, Thailand, Japan, North America, Europe, Australia and New Zealand, the amount of the benefit payable for each day of Hospital Confinement will be limited to 50% of the amount of Daily Hospital Income Benefit (and Family Daily Hospital Income Benefit, where applicable) and Intensive Care Benefit as shown on the Hospitalization Benefit Schedule, and subject to a maximum of 90 days for any one Disability (applicable for Daily Hospital Income Benefit and Intensive Care Benefit) or a maximum of 10 days for the Plan (applicable for Family Daily Hospital Income Benefit, where applicable). The Daily Hospital Income Benefit (and Family Daily Hospital Income Benefit, where applicable) and Intensive Care Benefit are payable on Medically Necessary Hospital Confinement basis. “Medically Necessary” means in respect of Hospital Confinement, treatment, procedure, supplies or other medical services, such Hospital Confinement, treatment, procedure, supplies or other medical services which are, in the Hong Kong Life’s opinion: (i) required for, appropriate and consistent with the symptoms and findings or diagnosis and treatment of the Disability; (ii) in accordance with generally accepted medical practice and not of an experimental or investigative nature; (iii) not for the convenience of the Policyowner, Life Insured (or the Covered Family Member, where applicable), or Registered Medical Practitioner or any other person; and (iv) not able to be omitted without adversely affecting the medical condition of the Life Insured (or the Covered Family Member, where applicable).
- “Hospital Confinement” means the admission and confinement of the Life Insured (or the Covered Family Member, where applicable) as an in-patient in a Hospital upon recommendation of a Registered Medical Practitioner for the treatment of a Disability provided that the Life Insured (or the Covered Family Member, where applicable) must be admitted in the Hospital as an in-patient for a minimum of 6 hours and continuously Stay in the Hospital thereafter prior to the Discharge of the Life Insured (or the Covered Family Member, where applicable), which incurs a charge for daily room and board of Hospital room or Intensive Care Unit. Hospital Confinement must be Medically Necessary.
- Family Daily Hospital Income Benefit for Policyowner’s legally married spouse or natural child, except the Life Insured (Covered Family Member) is only available if such spouse or child is accepted and approved by Hong Kong Life. Only one Covered Family Member can be covered under Family Daily Hospital Income Benefit. Spouse shall be (i) under the age of 60 at the time of application for Family Daily Hospital Income Benefit and (ii) under the age of 70 throughout the benefit term of the Plan. Child shall be attained the age of 15 days and is under the age of 18. Family Daily Hospital Income Benefit could be claimed a maximum of 10 days throughout the benefit term of the Plan. In no event shall the aggregate amount of benefit payable under the Family Daily Hospital Income Benefit of the Policy and all other insurance policies covering the Covered Family Member issued by Hong Kong Life from time to time, exceed a maximum aggregate amount of HKD1,500 for each day of Hospital Confinement. For detailed terms and conditions, please refer to relevant form and the policy document issued by Hong Kong Life.
- Second Medical Opinion from Overseas Expert Service is provided by third party service provider. Such service is not part of the product features. The availability of the service is not guaranteed. The details of the service will be provided along with the policy document or please refer to the company website of Hong Kong Life. Hong Kong Life reserves the right to cancel or amend the said service at its sole discretion. In addition, Hong Kong Life will not be responsible for any services or opinions provided by the third-party service provider. Hong Kong Life reserves the right of final decision in case of any dispute.
- The Policy will be terminated if the Policyowner cannot settle the premium payment before the end of the Grace Period during the Premium Payment Term, subject to the Non-forfeiture Option and other relevant provisions of the Policy. For detailed terms and conditions, please refer to the policy document issued by Hong Kong Life. If the Policy is terminated before the Maturity, the Guaranteed Surrender Value received by the Policyowner may be less than the Total Premiums Paid.
Hashtag: #HongKongLife
The issuer is solely responsible for the content of this announcement.
About Hong Kong Life
Established in 2001, Hong Kong Life Insurance Limited (“Hong Kong Life”) was founded by five local financial institutions including Asia Insurance Company Limited, Chong Hing Bank Limited, CMB Wing Lung Bank Limited, OCBC Wing Hang Bank Limited and Shanghai Commercial Bank Limited, which laid their foundations and have been serving people in Hong Kong for more than 50 years in average. Through our extensive network of around 140 distribution points comprising Chong Hing Bank, CMB Wing Lung Bank, OCBC Wing Hang and Shanghai Commercial Bank, we provide a comprehensive range of insurance services
Vietnam Starts its Biggest Lao Project Construction in Sekong

Construction of the Bauxite-Alumina Mining Industrial Complex began in Sekong’s Dakcheung district on 19 December.